Showing results (41-50 of 318) with videos related to
Sort By:
Pageof 32
Leukemia|September 1, 1995
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpointA Biondi, A Luciano, R Bassan, et al.Leukemia Research|November 1, 1993
Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cellsM Limonta, T Colombo, G Damia, et al.Haematologica|March 1, 1996
Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover studyS Molica, P Musto, F Chiurazzi, et al.Haematologica|November 6, 2001
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapyV Liso, S Molica, S Capalbo, et al.Bone Marrow Transplantation|April 13, 2004
Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cellsD Pastore, G Specchia, A Mestice, et al.Cancer|October 22, 1998
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven casesV Liso, G Specchia, E M Pogliani, et al.Bone Marrow Transplantation|April 22, 2008
Subsets of CD34+ and early engraftment kinetics in allogeneic peripheral SCT for AMLD Pastore, A Mestice, T Perrone, et al.Annals of Hematology|October 11, 2003
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1C T Storlazzi, L Anelli, F Albano, et al.European Journal of Haematology|April 1, 1990
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMAG Avvisati, F Mandelli, M C Petti, et al.Minerva Medica|June 30, 1983
[Prognostic usefulness of lysozyme in acute myelomonocytic leukemias]V Liso, R LaricchiaPageof 32